Breck Parker recently joined EnviroLogix as vice president of molecular diagnostic product development.
Parker joined EnviroLogix from GE Healthcare, where he was strategic development leader of the life sciences consumables division. Prior to that, he was development manager for Whatman, where he established a molecular biology and forensics DNA technology group and led the development of the EasiCollect buccal sample collection device widely used by federal and state crime labs.
Parker was also senior director of R&D at Eppendorf-5 Prime, where he focused on developing new kits for real-time PCR, sample preparation, novel thermophilic DNA polymerase discovery, and application development. Parker holds a PhD in molecular pharmacology from the University of Massachusetts.
Molecular diagnostics firm GenMark said this month that former president and CEO Jon Faiz Kayyem has been appointed to the newly established position of chief scientific officer. In this capacity, Kayyem will oversee all activities associated with menu expansion and platform development for GenMark.
Concurrently, GenMark said that Christopher Gleeson, former president and CEO of Ventana Medical Systems and current chairman of GenMark, has been appointed to the position of interim CEO. GenMark said that it will immediately commence the search process for a new CEO.